263 related articles for article (PubMed ID: 22020421)
21. Two MMP-2 promoter polymorphisms (-790T/G and -735C/T) in chronic heart failure.
Vasků A; Goldbergová M; Hollá LI; Spinarová L; Spinar J; Vítovec J; Vácha J
Clin Chem Lab Med; 2003 Oct; 41(10):1299-303. PubMed ID: 14580155
[TBL] [Abstract][Full Text] [Related]
22. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
23. Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome.
Bakry RM; El-Gezawy EM; Darwish AM; NasrEldin E; Gaber N; Nasif KA; El-Mohsen E; Mahfouz S
Indian J Hematol Blood Transfus; 2019 Jul; 35(3):471-477. PubMed ID: 31388259
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
25. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder.
Bobińska K; Szemraj J; Czarny P; Gałecki P
J Affect Disord; 2016 Nov; 205():119-129. PubMed ID: 27434116
[TBL] [Abstract][Full Text] [Related]
26. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.
Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D
Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease.
Marson BP; Lacchini R; Belo V; Dickel S; da Costa BP; Poli de Figueiredo CE; Tanus-Santos JE
Am J Nephrol; 2012; 35(3):209-15. PubMed ID: 22302011
[TBL] [Abstract][Full Text] [Related]
28. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
Oszajca K; Szemraj M; Szemraj J; Jurowski P
Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
[TBL] [Abstract][Full Text] [Related]
29. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
30. The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study.
Lin CM; Zeng YL; Xiao M; Mei XQ; Shen LY; Guo MX; Lin ZY; Liu QF; Yang T
Cell Physiol Biochem; 2017; 42(4):1458-1468. PubMed ID: 28719899
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Grieu F; Li WQ; Iacopetta B
Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
[TBL] [Abstract][Full Text] [Related]
32. Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma.
Diao LP; Yu XM; Gao YH; Li Y; Liu HS; Liu LH; Zhou RM; Wang N; Wu LL; Wang SJ
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1473-81. PubMed ID: 19649652
[TBL] [Abstract][Full Text] [Related]
33. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy.
Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):262-7. PubMed ID: 22672240
[TBL] [Abstract][Full Text] [Related]
34. The role of MMP2 (-1306C>T) and TIMP2 (-418 G>C) promoter variants in age-related macular degeneration.
Ortak H; Demir S; Ateş Ö; Benli İ; Söğüt E; Sahin M
Ophthalmic Genet; 2013 Dec; 34(4):217-22. PubMed ID: 23536957
[TBL] [Abstract][Full Text] [Related]
35. Analysis of MMP-9 and TIMP-2 gene promoter polymorphisms in individuals with hypodontia.
Peres RC; Line SR
Braz Dent J; 2005; 16(3):231-6. PubMed ID: 16429190
[TBL] [Abstract][Full Text] [Related]
36. Association of polymorphisms of the MMP-2 and TIMP-2 genes with the risk of endometriosis in North Chinese women.
Kang S; Zhao XW; Wang N; Chen SC; Zhou RM; Li Y
Fertil Steril; 2008 Nov; 90(5):2023-9. PubMed ID: 18177649
[TBL] [Abstract][Full Text] [Related]
37. The role of matrix metalloproteinase-2 promoter polymorphisms in coronary artery disease and myocardial infarction.
Alp E; Menevse S; Tulmac M; Yilmaz A; Yalcin R; Cengel A
Genet Test Mol Biomarkers; 2011 Apr; 15(4):193-202. PubMed ID: 21142815
[TBL] [Abstract][Full Text] [Related]
38. Genetic variations in the human gelatinase A (matrix metalloproteinase-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis.
Holla LI; Fassmann A; Vasku A; Goldbergova M; Beranek M; Znojil V; Vanek J; Vacha J
J Periodontol; 2005 Jul; 76(7):1056-60. PubMed ID: 16018746
[TBL] [Abstract][Full Text] [Related]
39. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181
[TBL] [Abstract][Full Text] [Related]
40. The relationship of metalloproteinase gene polymorphisms and lung cancer.
Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
